Myokines and Cognition
During contraction, skeletal muscle releases molecular factors that may affect cognitive function, such as BDNF, a neurotrophin required in adults for the maintenance of synaptic connections and adaptive neuronal plasticity, regulating cognitive processes such as learning and memory [
79]. A study showed that after long-term voluntary exercise, adult male mice exhibited a lactate-dependent increase in hippocampal BDNF [
80]. Interestingly, lactate (a metabolite released from muscle during exercise) was responsible for improvement in both learning and memory in these mice, and the induction of the hippocampal BDNF expression was found to be dependent on the sirtuin 1 (SIRT1)/peroxisome proliferator–activated receptor-γ coactivator 1-α (PGC1α)/fibronectin type III domain-containing 5 (FNDC5) pathway [
80]. Furthermore, SIRT1 knockout male mice were found to be more anxious than wild-type mice and suffering cognitive impairment characterized by reduced learning abilities and memory [
81]. In a rat model of AD, direct intervention in the hippocampus with the 42 amino acid form of amyloid β (Aβ1–42) resulted in cognitive impairment by suppressing PGC1α/FNDC5/BDNF signaling [
82]. However, the cognitive impairment was partially reversed by moderate physical activity, revealing a recovered PGC1α/ FNDC5/BDNF pathway [
82].
In addition, BDNF is released in response to muscle contraction [
83], and percutaneous electrical stimulation of the hindlimb muscles in a rat model of spinal cord injury significantly increased BDNF levels in both the anterior tibialis and the vertebral column [
84]. Importantly, deletion of BDNF in skeletal muscle in mice resulted in a fatigue-resistant muscle phenotype, migrating from fast to slow muscle fibers in glycolytic muscles tibialis anterior and extensor digitorum longus [
85]. In contrast, BDNF overexpression increased the glycolytic and fast fiber phenotype of the muscles [
85]. This is consistent with clinical findings, since BDNF levels in skeletal muscles induced by controlled physical activity were found to be correlated positively with muscle phenotypic changes favoring type II muscle fibers (fast and glycolytic) [
86]. Moreover, serum BDNF was increased in sedentary subjects 1 h after training, but this was not found in trained young and adult patients, suggesting the relevance of physical conditioning when assessing the effect of training on BDNF induction [
86]. In addition, the decrease of BDNF after training was correlated with improvement in cognitive processes such as visuospatial and verbal skills (measured using a before-and-after Addenbrooke’s Cognitive Examination-Revised test) [
86]. Consistent results have been obtained in experimental models, involving young and aged rats, suggesting a role of the PGC1α/ FNDC5/BDNF pathway in the protection of cognition from a musculoskeletal health approach [
87].
BDNF expression can also be affected by altered mastication. In growing mice receiving a soft diet, learning and memory processes were impaired, compared to mice eating standard chow, by the apparent decrease in masticatory function [
88]. In addition, BDNF expression in the hippocampus of mice receiving soft chow was decreased compared to those fed with standard chow, whereas no changes on the BDNF receptor were found in either group [
88]. Moreover, the reduced expression of BDNF was consistent with a decrease on the synapses, leading to degraded neuronal structure and therefore neural function [
88]. These findings are consistent with those of a recent systematic review of animal studies that identified a relationship between altered mastication and cognitive impairment characterized by decreased expression of BDNF in the hippocampus, decreased synapses, low performance in behavioral evaluations, and diminished memory and spatial location [
89••]. Interestingly, male rats fed with standard chow exhibited higher expression of BDNF hippocampus than those fed with either soft or hard chow [
90]. This result poses the question of whether reduced and increased masticatory functions are risk factors for cognitive impairment, suggesting a focus on clinical conditions ranging from loss of teeth (and therefore decreased masticatory function) to masticatory muscle parafunction. Short-term exposure of young adult male mice to a soft diet results in dysregulated expression neurodegenerative condition–related genes such as TREM2, DAP12, APOE, and CD33 in the microglia, suggesting that soft diet has an immunomodulatory role as a risk factor for cognitive impairment [
91]. Also, mastication on one side only has been shown to affect BDNF gene expression in the hippocampus, with cognitive impairment evaluated using the Morris Water Maze test in young adult male mice [
92•]. In addition, using the MWM test, it was determined that reduced physical activity and reduced masticatory function in adult and aged mice affected their memory and learning skills, but these were restored when normal mastication was enabled [
93]. The reduction of the branches in the astrocytes of the group with reduced physical activity and masticatory function [
93] is intriguing, suggesting the need for more research into the role of the mastication as a neuroprotective musculoskeletal activity. For instance, in humans, masticatory function has been evaluated as a neuroprotective activity based on its clinical correlation with increased brain blood perfusion [
27].
Irisin is a myokine released in response to physical activity, downstream of PGC1α/FNDC5 pathway activation, after FNDC5 cleavage [
94,
95]. Irisin stimulates BDNF expression in the hippocampus [
96], and is believed to mediate the effect of physical activity on BDNF expression [
94,
95]. Continuous physical training increases BDNF and Irisin serum levels, with benefits for cognitive performance, measured as the working memory (part of short memory that is a cognitive ability that can hold the information in mind for executing cognitive function tasks [
97]) in adults aged 50 to 70 years [
98]. In male mice, injection of Irisin to the hippocampus after physical restraint improved the cognitive response to memory tasks. However, female mice did not benefit from Irisin administration, suggesting a sex-dependent effect [
99]. Additionally, in FNDC5 knockout mice, absence of Irisin diminished cognitive skills (spatial and learning memory) after voluntary physical activity when compared with wild-type animals [
100]. Interestingly, the same study showed that systemically administered Irisin was able to cross the blood–brain barrier and partially rescue cognitive impairment in two AD mouse models [
100]. The mechanism of Irisin action remains to be fully understood. However, the use of AD mouse models has revealed a potential role of Irisin in neuroinflammation control [
100] and cognition improvement after physical activity, with increased levels of FDNC5, BDNF, and IL-6 [
101]. These findings can be compared and contrasted with clinical data about the correlation between Irisin levels in serum [
102] or cerebrospinal fluid [
103] and neurodegenerative/inflammatory biomarkers in conditions that affect cognition [
102,
103].